Efficacy and Acceptability of Tadenan®(Pygeum africanum Extract) in the Treatment of Benign Prostatic Hyperplasia (BPH): A Multicentre Trial in Central Europe
- 1 January 1998
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 14 (3) , 127-139
- https://doi.org/10.1185/03007999809113352
Abstract
SummaryPygeum africanum extract is available as Tadenan ® in many countries, including those in central and eastern Europe, for the treatment of mild to moderate BPH. Its efficacy and acceptability have been demonstrated in numerous open and placebo-controlled studies in large populations. The present open three-centre efficacy and safety study was conducted according to common protocol at urology clinics in the Czech and Slovak Republics and in Poland, in order to confirm the therapeutic profile o/Pygeum africanum in conditions of daily practice, using International Prostate Symptom Score (IPSS) andflowmetry assessments.Men aged 50-75 years and in compliance with the selection criteria (including IPSS ≥ 12, quality of life (QoL) score ≥ 3, and maximum urinary flow ≤ 15 mils) were first examined then recalled after two weeks during which no treatment was provided (washout and check of stability). If still compliant, they were entered at this point into a two-month period of treatment with Pygeum africanum...Keywords
This publication has 13 references indexed in Scilit:
- Placebo Effects in the Pharmacological Treatment of Uncomplicated Benign Prostatic HyperplasiaScandinavian Journal of Urology and Nephrology, 1996
- Plasma Neuroendocrine Markers in Patients with Benign Prostatic Hyperplasia and Prostatic CarcinomaJournal of Urology, 1996
- Efficacy, tolerability, and effect on health-related quality of life of finasteride versus placebo in men with symptomatic benign prostatic hyperplasia: a community-based studyClinical Therapeutics, 1995
- Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995
- Pygeum africanum extract for the treatment of patients with benign prostatic hyperplasia: A review of 25 years of published experienceCurrent Therapeutic Research, 1995
- Benign Prostatic HyperplasiaDrugs, 1994
- Efficacy and Safety of the Alpha-1 Blocker Doxazosin in the Treatment of Benign Prostatic HyperplasiaEuropean Urology, 1993
- The American Urological Association Symptom Index for Benign Prostatic HyperplasiaJournal of Urology, 1992
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984